Within 24 hours, 33,000 people said they had received the Atrazinc vaccine

The chairman of the CNCAV board, said on Tuesday, that about 33,000 people who signed up for the AstraZeneca vaccine in the past 24 years have announced the vaccination date.

Valerio Georgi According to AstraZeneca, about 33,000 of the 446,896 people registered on the platform have resigned. Meanwhile, there were more than 100,000 free days at centers using this vaccine, and the number dropped to 18,347 on Tuesday. Currently, 168,027 people have been registered for the first drink of AstraZeneca vaccine, and about 419,000 people are expected to receive the second drink.

Last week, the expert referred to 13 European countries Dent ingTemporarily suspending the use of one of the supplies of AstraZeneca vaccine, to continue using all supplies in the event of a cold, and in 15 countries, the vaccine is not vaccinated at all. And vaccination with this vaccine continues at the level of Britain, Canada and Australia.

Gheorghi assured that Romnia decided to continue using the product, which has been approved by the European Medicines Agency (EMA), in which case the risks / benefits will still be favorable. He pointed out that it was very difficult to make the decision, but it had to be considered, as the number of cases is increasing day by day, and more and more people need intensive care. Of the 17 million people vaccinated with AstraZeneca, 37 had clots, 15 had thrombosis, and 22 had clots.

Gheorghi explained that EMA and WHO recommendations are constantly being followed, and a decision is made if necessary. In the meantime, we recommend that both healthcare professionals and vaccines report side effects after vaccination.

READ  Live updates: Oregon Ducks vs USC Trojans in the Pac-12 tournament game

The European Medicines Agency met on Tuesday Lead between him andAccording to their studies, there is no indication that the vaccine causes vrrgkpzdst.

If you liked the article, check out Transindex!

Leave a Reply

Your email address will not be published. Required fields are marked *